|
|
Article: FDA Approves Clarinex for Seasonal Allergic Rhinitis.
- Article from:
- Immunotherapy Weekly
- Article date:
- January 23, 2002
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 JAN 23 - (NewsRx.com & NewsRx.net) -- Schering-Plough Corp.'s Clarinex (desloratadine) 5 mg tablets has received marketing clearance from the U.S. Food and Drug Administration for the treatment of seasonal allergic rhinitis (SAR) in adults and children 12 years of age and older.
Clarinex is a new, once-daily, nonsedating antihistamine that provides 24-hour relief from the symptoms of SAR. An H-1 receptor antagonist, Clarinex Tablets taken once daily in clinical trials significantly reduced total symptom scores of the nasal and non-nasal symptoms of seasonal allergies.
"Discovered and developed by Schering-Plough scientists, Clarinex represents a ...